Literature DB >> 24252781

Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Jillian Zientek1, F Scott Dahlgren2, Jennifer H McQuiston2, Joanna Regan3.   

Abstract

Among 2012 Docstyle survey respondents, 80% identified doxycycline as the appropriate treatment for Rocky Mountain spotted fever in patients ≥ 8 years old, but only 35% correctly chose doxycycline in patients <8 years old. These findings raise concerns about the higher pediatric case-fatality rate of Rocky Mountain spotted fever observed nationally. Targeted education efforts are needed. Crown
Copyright © 2014. Published by Mosby, Inc. All rights reserved.

Entities:  

Keywords:  CME; Continuing medical education; HCP; Healthcare provider; RMSF; Rocky Mountain spotted fever

Mesh：

Substances：

Year:  2013        PMID： 24252781      PMCID： PMC4699435          DOI： 10.1016/j.jpeds.2013.10.008

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  8 in total

1.  Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy.

Authors:  R C Holman; C D Paddock; A T Curns; J W Krebs; J H McQuiston; J E Childs
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

2.  Absence of tooth staining with doxycycline treatment in young children.

Authors:  Benjamin Volovitz; Ronit Shkap; Jacob Amir; Shlomo Calderon; Izhak Varsano; Moshe Nussinovitch
Journal:  Clin Pediatr (Phila)       Date:  2007-03       Impact factor: 1.168

3.  Knowledge, attitudes, and practices regarding Rocky Mountain spotted fever among healthcare providers, Tennessee, 2009.

Authors:  Emily Mosites; L Rand Carpenter; Kristina McElroy; Mary J Lancaster; Tue H Ngo; Jennifer McQuiston; Caleb Wiedeman; John R Dunn
Journal:  Am J Trop Med Hyg       Date:  2012-12-12       Impact factor: 2.345

4.  Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

Authors:  John J Openshaw; David L Swerdlow; John W Krebs; Robert C Holman; Eric Mandel; Alexis Harvey; Dana Haberling; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

5.  Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals.

Authors:  Alice S Chapman; Johan S Bakken; Scott M Folk; Christopher D Paddock; Karen C Bloch; Allan Krusell; Daniel J Sexton; Steven C Buckingham; Gary S Marshall; Gregory A Storch; Gregory A Dasch; Jennifer H McQuiston; David L Swerdlow; Stephen J Dumler; William L Nicholson; David H Walker; Marina E Eremeeva; Christopher A Ohl
Journal:  MMWR Recomm Rep       Date:  2006-03-31

6.  Fatal Rocky Mountain spotted fever in the United States, 1999-2007.

Authors:  F Scott Dahlgren; Robert C Holman; Christopher D Paddock; Laura S Callinan; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

7.  Therapeutic delay and mortality in cases of Rocky Mountain spotted fever.

Authors:  K B Kirkland; W E Wilkinson; D J Sexton
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

Review 8.  The use and safety of doxycycline hyclate and other second-generation tetracyclines.

Authors:  Barry Sloan; Noah Scheinfeld
Journal:  Expert Opin Drug Saf       Date:  2008-09       Impact factor: 4.250
  8 in total
  10 in total

1.  Increase in Reports of Tick-Borne Rickettsial Diseases in the United States.

Authors:  Alison M Binder; Paige A Armstrong
Journal:  Am J Nurs       Date:  2019-07       Impact factor: 2.220

2.  Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012.

Authors:  Kristen Nichols Heitman; F Scott Dahlgren; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

3.  Impact of a Severe Rocky Mountain Spotted Fever Case on Treatment Practices at an Academic Institution Within a Nonendemic Area.

Authors:  Conrad Krawiec; Gary D Ceneviva; Shouhao Zhou; Neal J Thomas
Journal:  Wilderness Environ Med       Date:  2021-08-12       Impact factor: 1.518

4.  Challenges to Arboviral Surveillance in Tennessee: Health-Care Providers' Attitudes and Behaviors.

Authors:  Julie Shaffner; Timothy F Jones; Abelardo C Moncayo
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

Review 5.  Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation?

Authors:  Ruby Cross; Clare Ling; Nicholas P J Day; Rose McGready; Daniel H Paris
Journal:  Expert Opin Drug Saf       Date:  2016-01-25       Impact factor: 4.250

6.  Molecular confirmation & characterization of Rickettsia conorii in north India: A report of three cases.

Authors:  Manisha Biswal; Kamran Zaman; Vikas Suri; Srikanth Gopi; Abhay Kumar; T Gopi; Shashi Vig; Navneet Sharma; Ashish Bhalla
Journal:  Indian J Med Res       Date:  2020-01       Impact factor: 2.375

7.  Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005-2017.

Authors:  Alison M Binder; Paige A Armstrong
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.996

Review 8.  A forty-year review of Rocky Mountain spotted fever cases in California shows clinical and epidemiologic changes.

Authors:  Anne M Kjemtrup; Kerry Padgett; Christopher D Paddock; Sharon Messenger; Jill K Hacker; Tina Feiszli; Michael Melgar; Marco E Metzger; Renjie Hu; Vicki L Kramer
Journal:  PLoS Negl Trop Dis       Date:  2022-09-15

Review 9.  Zoonosis: Update on Existing and Emerging Vector-Borne Illnesses in the USA.

Authors:  Sandra Lee Werner; Bhanu Kirthi Banda; Christopher Lee Burnsides; Alexander James Stuber
Journal:  Curr Emerg Hosp Med Rep       Date:  2019-08-13

10.  Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.

Authors:  Kevin Kuriakose; April C Pettit; Jonathan Schmitz; Abelardo Moncayo; Karen C Bloch
Journal:  JAMA Netw Open       Date:  2020-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.